REGISTER NOW
FOR THE 18TH ANNUAL 5K RUN AND WALK FOR LUPUS  Sunday, June 10, 2012 | West Valley College, Saratoga
TEAM STANDINGS
as of 5/28/12:
Largest Team
1.Team Von Raesfeld
2. Team Remley
3. Roberta's Hope for Research
Top Fundraising Team
1. Roberta's Hope for Research
2. The Butterfly Effect
3. Team Von Raesfeld Also announcing...
1. Niner (Defending Champion) 2. Huckelberry
|
"DOUBLE THE PACE" FUND CAMPAIGN
As of May 28, 2012, we have reached 69% of our goal. Please help us reach our goal of $68,000 by June 30, 2012.
|
Information contained in this e-Newsletter should not be considered a substitute for professional diagnosis, treatment or management of S.L.E. and symptoms by a physician.
Missed a previous issue of this e-Newsletter?
You can now view our ARCHIVES.
Editor: Rene Astudillo
Editorial Assistant: Spandan Chakrabarti |
|
Connect with us on
via "Lupus Online"
|
LFNC's Social Media Program is funded through a generous grant from THE HENRY L. GUENTHER FOUNDATION GEORGE H. SANDY FOUNDATION 
|
|
|
|
Experimental Drug Lupuzor Granted Fast-Track Designation By FDA
The U.S. Food and Drug Administration (FDA) has granted fast-track designation for the experimental lupus treatment, Lupuzor. The designation means that the review will be given priority to go faster than usual. FDA often grants this accelerated process to drugs that show promise in treating serious, life-threatening medical conditions for which no other drug either exists or works as well.
The FDA also gave its approval to the company that developed the drug, ImmuPharma to begin a Phase III clinical trial. A Phase III trial is often the last step before the company testing the drug submits an application to the FDA for it to be approved as a new treatment.
Lupuzor™ (previously known as IPP-201101) has a novel mechanism of action aimed at adjusting the body's immune system so it does not attack healthy cells without causing adverse side effects. It has the potential to stop the progression of the disease in a substantial proportion of patients.
Benlysta, the first new lupus drug in over 50 years, also received a fast-track designation prior to its approval by the FDA in March of 2011.
For status updates on Lupuzor's Phase III clinical trial, check the lupus trials website.
|
5K RUN & WALK FOR LUPUS:
DEADLINE FOR ONLINE REGISTRATION THIS THURSDAY, MAY 31, 2012
Register NOW to save $5 and to avoid long lines on event day. (Onsite registration is available at $30 on June 10, 2012 at West Valley College in Saratoga starting at 7:30 am.
|
|
|
|
PLEASE HELP US REACH OUR FUNDRAISING GOAL FOR
LFNC'S CHARITY CAR DRAWINGPurchase your entries NOW!! (Current odds of winning 1 in 300 chances!)
Win this 2012 Honda Civic Sedan LX See DETAILS
|
Attention LFNC supporters!
Have you been to LFNC's new online shopping website?
If not, now is your chance to visit the site and register as a preferred customer!
www.shop.com/LFNC
Announcement!!! There will be a drawing at the LFNC Walk on
June 10, 2012. All supporters who are registered as of June 10, will be entered into a drawing for some great prizes- including gift cards to your favorite stores!
Then, stop by the Shop.com/LFNC table at the Walk and receive an additional entry!
Grand Prize Winner and Runner Up prizes valued at over $200.
(You do not need to be present to win).
For website help or questions, call LFNC Shop.com Customer Manager, Janelle Brown (916) 717-0094.
Have fun checking out the site and see you at the walk!
|
|
LFNC is an active partner in
|
The LFNC Office is closed today, MEMORIAL DAY
|
|
|
